vVARDIS is developing Curodont, a non-invasive, peptide-based treatment for caries. Funds managed by Apollo are taking a strategic minority stake, for an undisclosed amount, that values the company at more than USD 1 billion.
- Announced on
- Round
- Undisclosed round
- Amount
- Amount not disclosed
- Location
- Zug
- Sector
- Health & medtech
Investors
- Apollo
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic